nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Loratadine—atopic dermatitis	0.0639	0.426	CbGbCtD
Treprostinil—CYP2C9—Diphenhydramine—atopic dermatitis	0.0639	0.426	CbGbCtD
Treprostinil—CYP2C9—Dexamethasone—atopic dermatitis	0.0221	0.147	CbGbCtD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—SELE—atopic dermatitis	0.00527	0.0336	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00514	0.0328	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—GLB1—atopic dermatitis	0.00417	0.0266	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00415	0.0264	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors—PPARA—atopic dermatitis	0.00379	0.0242	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—STAT6—atopic dermatitis	0.00311	0.0199	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.003	0.0191	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00282	0.018	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00252	0.0161	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00232	0.0148	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—NPS—atopic dermatitis	0.00228	0.0145	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.00226	0.0144	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00224	0.0143	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00207	0.0132	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00201	0.0128	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL22—atopic dermatitis	0.00192	0.0122	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00185	0.0118	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL22—atopic dermatitis	0.00177	0.0113	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL27—atopic dermatitis	0.00171	0.0109	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00166	0.0106	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00162	0.0104	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL27—atopic dermatitis	0.00157	0.01	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00154	0.00985	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL17—atopic dermatitis	0.00153	0.00978	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00149	0.00953	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00145	0.00928	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.00145	0.00924	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00142	0.00906	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—PPARA—atopic dermatitis	0.00142	0.00905	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL17—atopic dermatitis	0.00141	0.009	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00135	0.00861	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00134	0.00855	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00132	0.00844	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00124	0.00792	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL11—atopic dermatitis	0.00124	0.00788	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KIF3A—atopic dermatitis	0.00122	0.00779	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00122	0.00776	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00118	0.00752	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00118	0.00752	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00118	0.0075	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00116	0.00737	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL11—atopic dermatitis	0.00114	0.00725	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KIF3A—atopic dermatitis	0.00112	0.00717	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.00109	0.00697	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00109	0.00692	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00109	0.00692	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00106	0.00679	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00101	0.00645	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCR3—atopic dermatitis	0.00101	0.00643	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SELE—atopic dermatitis	0.000985	0.00628	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL22—atopic dermatitis	0.000984	0.00628	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCL27—atopic dermatitis	0.000966	0.00616	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000935	0.00596	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCR3—atopic dermatitis	0.000927	0.00591	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000912	0.00581	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SELE—atopic dermatitis	0.000906	0.00578	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL22—atopic dermatitis	0.000906	0.00578	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—TAC1—atopic dermatitis	0.000898	0.00573	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—NPS—atopic dermatitis	0.000898	0.00573	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000889	0.00567	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCR3—atopic dermatitis	0.000881	0.00562	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL27—atopic dermatitis	0.000877	0.00559	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00086	0.00549	CbGpPWpGaD
Treprostinil—Rash—Mometasone—atopic dermatitis	0.000847	0.00122	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000846	0.0054	CbGpPWpGaD
Treprostinil—Dermatitis—Mometasone—atopic dermatitis	0.000846	0.00122	CcSEcCtD
Treprostinil—Body temperature increased—Tacrolimus—atopic dermatitis	0.000845	0.00122	CcSEcCtD
Treprostinil—Abdominal pain—Tacrolimus—atopic dermatitis	0.000845	0.00122	CcSEcCtD
Treprostinil—Headache—Mometasone—atopic dermatitis	0.000841	0.00121	CcSEcCtD
Treprostinil—Erythema—Prednisolone—atopic dermatitis	0.000837	0.00121	CcSEcCtD
Treprostinil—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000835	0.0012	CcSEcCtD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000834	0.00532	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—NPS—atopic dermatitis	0.000826	0.00527	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—TAC1—atopic dermatitis	0.000826	0.00527	CbGpPWpGaD
Treprostinil—Erythema—Hydrocortisone—atopic dermatitis	0.000817	0.00118	CcSEcCtD
Treprostinil—Bradycardia—Betamethasone—atopic dermatitis	0.000816	0.00118	CcSEcCtD
Treprostinil—Bradycardia—Dexamethasone—atopic dermatitis	0.000816	0.00118	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCR3—atopic dermatitis	0.00081	0.00517	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL27—atopic dermatitis	0.000807	0.00515	CbGpPWpGaD
Treprostinil—Haemoglobin—Betamethasone—atopic dermatitis	0.000806	0.00116	CcSEcCtD
Treprostinil—Haemoglobin—Dexamethasone—atopic dermatitis	0.000806	0.00116	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000805	0.00513	CbGpPWpGaD
Treprostinil—Haemorrhage—Dexamethasone—atopic dermatitis	0.000802	0.00116	CcSEcCtD
Treprostinil—Haemorrhage—Betamethasone—atopic dermatitis	0.000802	0.00116	CcSEcCtD
Treprostinil—Nausea—Mometasone—atopic dermatitis	0.000798	0.00115	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCL17—atopic dermatitis	0.000787	0.00502	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000779	0.00497	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000776	0.00112	CcSEcCtD
Treprostinil—Depression—Prednisone—atopic dermatitis	0.000776	0.00112	CcSEcCtD
Treprostinil—Erythema—Triamcinolone—atopic dermatitis	0.000769	0.00111	CcSEcCtD
Treprostinil—Erythema—Methylprednisolone—atopic dermatitis	0.000768	0.00111	CcSEcCtD
Treprostinil—Asthenia—Tacrolimus—atopic dermatitis	0.000767	0.00111	CcSEcCtD
Treprostinil—Angioedema—Prednisolone—atopic dermatitis	0.000764	0.0011	CcSEcCtD
Treprostinil—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000758	0.00109	CcSEcCtD
Treprostinil—Pruritus—Tacrolimus—atopic dermatitis	0.000756	0.00109	CcSEcCtD
Treprostinil—Malaise—Prednisolone—atopic dermatitis	0.000754	0.00109	CcSEcCtD
Treprostinil—Syncope—Prednisolone—atopic dermatitis	0.00075	0.00108	CcSEcCtD
Treprostinil—Angioedema—Hydrocortisone—atopic dermatitis	0.000746	0.00108	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IL5—atopic dermatitis	0.000746	0.00476	CbGpPWpGaD
Treprostinil—Back pain—Triamcinolone—atopic dermatitis	0.000744	0.00107	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00074	0.00472	CbGpPWpGaD
Treprostinil—Malaise—Hydrocortisone—atopic dermatitis	0.000737	0.00106	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisolone—atopic dermatitis	0.000735	0.00106	CcSEcCtD
Treprostinil—Syncope—Hydrocortisone—atopic dermatitis	0.000733	0.00106	CcSEcCtD
Treprostinil—Diarrhoea—Tacrolimus—atopic dermatitis	0.000731	0.00105	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000725	0.00462	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL17—atopic dermatitis	0.000724	0.00462	CbGpPWpGaD
Treprostinil—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000718	0.00104	CcSEcCtD
Treprostinil—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000714	0.00103	CcSEcCtD
Treprostinil—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000712	0.00103	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCL10—atopic dermatitis	0.000712	0.00454	CbGpPWpGaD
Treprostinil—Bradycardia—Prednisone—atopic dermatitis	0.000711	0.00103	CcSEcCtD
Treprostinil—Dizziness—Tacrolimus—atopic dermatitis	0.000707	0.00102	CcSEcCtD
Treprostinil—Discomfort—Prednisolone—atopic dermatitis	0.000704	0.00101	CcSEcCtD
Treprostinil—Angioedema—Triamcinolone—atopic dermatitis	0.000703	0.00101	CcSEcCtD
Treprostinil—Haemoglobin—Prednisone—atopic dermatitis	0.000702	0.00101	CcSEcCtD
Treprostinil—Angioedema—Methylprednisolone—atopic dermatitis	0.000701	0.00101	CcSEcCtD
Treprostinil—Haemorrhage—Prednisone—atopic dermatitis	0.000698	0.00101	CcSEcCtD
Treprostinil—Erythema—Betamethasone—atopic dermatitis	0.000698	0.00101	CcSEcCtD
Treprostinil—Erythema—Dexamethasone—atopic dermatitis	0.000698	0.00101	CcSEcCtD
Treprostinil—Myalgia—Hydrocortisone—atopic dermatitis	0.000696	0.001	CcSEcCtD
Treprostinil—Malaise—Triamcinolone—atopic dermatitis	0.000694	0.001	CcSEcCtD
Treprostinil—Anxiety—Hydrocortisone—atopic dermatitis	0.000693	0.001	CcSEcCtD
Treprostinil—Malaise—Methylprednisolone—atopic dermatitis	0.000692	0.000998	CcSEcCtD
Treprostinil—Syncope—Triamcinolone—atopic dermatitis	0.00069	0.000995	CcSEcCtD
Treprostinil—Syncope—Methylprednisolone—atopic dermatitis	0.000688	0.000993	CcSEcCtD
Treprostinil—Discomfort—Hydrocortisone—atopic dermatitis	0.000687	0.000991	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IL5—atopic dermatitis	0.000687	0.00438	CbGpPWpGaD
Treprostinil—Oedema—Prednisolone—atopic dermatitis	0.000683	0.000985	CcSEcCtD
Treprostinil—Vomiting—Tacrolimus—atopic dermatitis	0.00068	0.00098	CcSEcCtD
Treprostinil—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000676	0.000975	CcSEcCtD
Treprostinil—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000675	0.000973	CcSEcCtD
Treprostinil—Rash—Tacrolimus—atopic dermatitis	0.000674	0.000972	CcSEcCtD
Treprostinil—Dermatitis—Tacrolimus—atopic dermatitis	0.000673	0.000971	CcSEcCtD
Treprostinil—Shock—Prednisolone—atopic dermatitis	0.000672	0.000969	CcSEcCtD
Treprostinil—Cough—Triamcinolone—atopic dermatitis	0.000671	0.000968	CcSEcCtD
Treprostinil—Headache—Tacrolimus—atopic dermatitis	0.00067	0.000966	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000667	0.00425	CbGpPWpGaD
Treprostinil—Oedema—Hydrocortisone—atopic dermatitis	0.000667	0.000962	CcSEcCtD
Treprostinil—Tachycardia—Prednisolone—atopic dermatitis	0.000666	0.000961	CcSEcCtD
Treprostinil—Infection—Hydrocortisone—atopic dermatitis	0.000662	0.000955	CcSEcCtD
Treprostinil—Shock—Hydrocortisone—atopic dermatitis	0.000656	0.000946	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000655	0.00418	CbGpPWpGaD
Treprostinil—Myalgia—Triamcinolone—atopic dermatitis	0.000655	0.000945	CcSEcCtD
Treprostinil—Myalgia—Methylprednisolone—atopic dermatitis	0.000653	0.000942	CcSEcCtD
Treprostinil—Arthralgia—Methylprednisolone—atopic dermatitis	0.000653	0.000942	CcSEcCtD
Treprostinil—Anxiety—Methylprednisolone—atopic dermatitis	0.000651	0.000939	CcSEcCtD
Treprostinil—Tachycardia—Hydrocortisone—atopic dermatitis	0.000651	0.000939	CcSEcCtD
Treprostinil—Flushing—Prednisone—atopic dermatitis	0.000648	0.000935	CcSEcCtD
Treprostinil—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000648	0.000934	CcSEcCtD
Treprostinil—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000648	0.000934	CcSEcCtD
Treprostinil—Discomfort—Triamcinolone—atopic dermatitis	0.000647	0.000933	CcSEcCtD
Treprostinil—Discomfort—Methylprednisolone—atopic dermatitis	0.000646	0.000931	CcSEcCtD
Treprostinil—Angioedema—Dexamethasone—atopic dermatitis	0.000638	0.00092	CcSEcCtD
Treprostinil—Angioedema—Betamethasone—atopic dermatitis	0.000638	0.00092	CcSEcCtD
Treprostinil—Anorexia—Hydrocortisone—atopic dermatitis	0.000636	0.000917	CcSEcCtD
Treprostinil—Nausea—Tacrolimus—atopic dermatitis	0.000635	0.000916	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCL11—atopic dermatitis	0.000634	0.00404	CbGpPWpGaD
Treprostinil—Malaise—Betamethasone—atopic dermatitis	0.000629	0.000908	CcSEcCtD
Treprostinil—Malaise—Dexamethasone—atopic dermatitis	0.000629	0.000908	CcSEcCtD
Treprostinil—Oedema—Triamcinolone—atopic dermatitis	0.000628	0.000906	CcSEcCtD
Treprostinil—Syncope—Betamethasone—atopic dermatitis	0.000626	0.000903	CcSEcCtD
Treprostinil—Syncope—Dexamethasone—atopic dermatitis	0.000626	0.000903	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—FCER2—atopic dermatitis	0.000625	0.00399	CbGpPWpGaD
Treprostinil—Infection—Triamcinolone—atopic dermatitis	0.000624	0.0009	CcSEcCtD
Treprostinil—Hypotension—Hydrocortisone—atopic dermatitis	0.000623	0.000899	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TNF—atopic dermatitis	0.000623	0.00397	CbGpPWpGaD
Treprostinil—Infection—Methylprednisolone—atopic dermatitis	0.000622	0.000898	CcSEcCtD
Treprostinil—Shock—Triamcinolone—atopic dermatitis	0.000618	0.000891	CcSEcCtD
Treprostinil—Insomnia—Prednisolone—atopic dermatitis	0.000617	0.000891	CcSEcCtD
Treprostinil—Shock—Methylprednisolone—atopic dermatitis	0.000616	0.000889	CcSEcCtD
Treprostinil—Loss of consciousness—Betamethasone—atopic dermatitis	0.000613	0.000885	CcSEcCtD
Treprostinil—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000613	0.000885	CcSEcCtD
Treprostinil—Paraesthesia—Prednisolone—atopic dermatitis	0.000613	0.000884	CcSEcCtD
Treprostinil—Tachycardia—Triamcinolone—atopic dermatitis	0.000613	0.000884	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCL5—atopic dermatitis	0.000613	0.00391	CbGpPWpGaD
Treprostinil—Tachycardia—Methylprednisolone—atopic dermatitis	0.000611	0.000882	CcSEcCtD
Treprostinil—Erythema—Prednisone—atopic dermatitis	0.000608	0.000877	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000607	0.000876	CcSEcCtD
Treprostinil—Insomnia—Hydrocortisone—atopic dermatitis	0.000603	0.00087	CcSEcCtD
Treprostinil—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000599	0.000864	CcSEcCtD
Treprostinil—PPARD—Metabolism—GLB1—atopic dermatitis	0.000597	0.00381	CbGpPWpGaD
Treprostinil—Myalgia—Betamethasone—atopic dermatitis	0.000594	0.000857	CcSEcCtD
Treprostinil—Myalgia—Dexamethasone—atopic dermatitis	0.000594	0.000857	CcSEcCtD
Treprostinil—Anxiety—Dexamethasone—atopic dermatitis	0.000592	0.000854	CcSEcCtD
Treprostinil—Anxiety—Betamethasone—atopic dermatitis	0.000592	0.000854	CcSEcCtD
Treprostinil—Discomfort—Dexamethasone—atopic dermatitis	0.000587	0.000847	CcSEcCtD
Treprostinil—Discomfort—Betamethasone—atopic dermatitis	0.000587	0.000847	CcSEcCtD
Treprostinil—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000587	0.000847	CcSEcCtD
Treprostinil—Hypotension—Methylprednisolone—atopic dermatitis	0.000585	0.000844	CcSEcCtD
Treprostinil—Pain—Prednisolone—atopic dermatitis	0.000584	0.000842	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CCL11—atopic dermatitis	0.000584	0.00372	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL22—atopic dermatitis	0.000581	0.00371	CbGpPWpGaD
Treprostinil—Decreased appetite—Hydrocortisone—atopic dermatitis	0.00058	0.000836	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—FCER2—atopic dermatitis	0.000576	0.00367	CbGpPWpGaD
Treprostinil—Fatigue—Hydrocortisone—atopic dermatitis	0.000575	0.000829	CcSEcCtD
Treprostinil—PPARD—Metabolism—ADSL—atopic dermatitis	0.000573	0.00365	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000572	0.000825	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000571	0.000823	CcSEcCtD
Treprostinil—Pain—Hydrocortisone—atopic dermatitis	0.00057	0.000822	CcSEcCtD
Treprostinil—Oedema—Betamethasone—atopic dermatitis	0.00057	0.000822	CcSEcCtD
Treprostinil—Oedema—Dexamethasone—atopic dermatitis	0.00057	0.000822	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCR3—atopic dermatitis	0.000569	0.00363	CbGpPWpGaD
Treprostinil—Insomnia—Triamcinolone—atopic dermatitis	0.000568	0.000819	CcSEcCtD
Treprostinil—Insomnia—Methylprednisolone—atopic dermatitis	0.000567	0.000817	CcSEcCtD
Treprostinil—Infection—Dexamethasone—atopic dermatitis	0.000566	0.000816	CcSEcCtD
Treprostinil—Infection—Betamethasone—atopic dermatitis	0.000566	0.000816	CcSEcCtD
Treprostinil—Ill-defined disorder—Prednisone—atopic dermatitis	0.000564	0.000813	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCL5—atopic dermatitis	0.000564	0.0036	CbGpPWpGaD
Treprostinil—Paraesthesia—Triamcinolone—atopic dermatitis	0.000564	0.000813	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisolone—atopic dermatitis	0.000563	0.000811	CcSEcCtD
Treprostinil—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000562	0.000811	CcSEcCtD
Treprostinil—Anaemia—Prednisone—atopic dermatitis	0.000562	0.00081	CcSEcCtD
Treprostinil—Shock—Dexamethasone—atopic dermatitis	0.00056	0.000808	CcSEcCtD
Treprostinil—Shock—Betamethasone—atopic dermatitis	0.00056	0.000808	CcSEcCtD
Treprostinil—Dyspnoea—Triamcinolone—atopic dermatitis	0.00056	0.000807	CcSEcCtD
Treprostinil—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000558	0.000804	CcSEcCtD
Treprostinil—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000558	0.000804	CcSEcCtD
Treprostinil—Tachycardia—Betamethasone—atopic dermatitis	0.000556	0.000802	CcSEcCtD
Treprostinil—Tachycardia—Dexamethasone—atopic dermatitis	0.000556	0.000802	CcSEcCtD
Treprostinil—Angioedema—Prednisone—atopic dermatitis	0.000555	0.000801	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000553	0.00353	CbGpPWpGaD
Treprostinil—Dyspepsia—Triamcinolone—atopic dermatitis	0.000553	0.000797	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCR5—atopic dermatitis	0.000552	0.00352	CbGpPWpGaD
Treprostinil—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000551	0.000795	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000551	0.00352	CbGpPWpGaD
Treprostinil—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000549	0.000792	CcSEcCtD
Treprostinil—Malaise—Prednisone—atopic dermatitis	0.000548	0.000791	CcSEcCtD
Treprostinil—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000545	0.000786	CcSEcCtD
Treprostinil—Syncope—Prednisone—atopic dermatitis	0.000545	0.000786	CcSEcCtD
Treprostinil—Anorexia—Betamethasone—atopic dermatitis	0.000543	0.000783	CcSEcCtD
Treprostinil—Anorexia—Dexamethasone—atopic dermatitis	0.000543	0.000783	CcSEcCtD
Treprostinil—Fatigue—Triamcinolone—atopic dermatitis	0.000541	0.000781	CcSEcCtD
Treprostinil—Fatigue—Methylprednisolone—atopic dermatitis	0.00054	0.000779	CcSEcCtD
Treprostinil—Pain—Triamcinolone—atopic dermatitis	0.000537	0.000774	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CCL22—atopic dermatitis	0.000535	0.00341	CbGpPWpGaD
Treprostinil—Loss of consciousness—Prednisone—atopic dermatitis	0.000534	0.000771	CcSEcCtD
Treprostinil—Hypotension—Dexamethasone—atopic dermatitis	0.000532	0.000768	CcSEcCtD
Treprostinil—Hypotension—Betamethasone—atopic dermatitis	0.000532	0.000768	CcSEcCtD
Treprostinil—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000527	0.00076	CcSEcCtD
Treprostinil—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000527	0.00076	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000524	0.00334	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000519	0.000749	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000519	0.000749	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CCL27—atopic dermatitis	0.000518	0.0033	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000518	0.0033	CbGpPWpGaD
Treprostinil—Myalgia—Prednisone—atopic dermatitis	0.000518	0.000746	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—atopic dermatitis	0.000518	0.000746	CcSEcCtD
Treprostinil—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000517	0.000746	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCR3—atopic dermatitis	0.000517	0.0033	CbGpPWpGaD
Treprostinil—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000516	0.000745	CcSEcCtD
Treprostinil—Anxiety—Prednisone—atopic dermatitis	0.000516	0.000744	CcSEcCtD
Treprostinil—Insomnia—Betamethasone—atopic dermatitis	0.000515	0.000743	CcSEcCtD
Treprostinil—Insomnia—Dexamethasone—atopic dermatitis	0.000515	0.000743	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000512	0.000739	CcSEcCtD
Treprostinil—Paraesthesia—Dexamethasone—atopic dermatitis	0.000512	0.000738	CcSEcCtD
Treprostinil—Paraesthesia—Betamethasone—atopic dermatitis	0.000512	0.000738	CcSEcCtD
Treprostinil—Discomfort—Prednisone—atopic dermatitis	0.000511	0.000737	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCR5—atopic dermatitis	0.000508	0.00324	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—NPS—atopic dermatitis	0.000507	0.00324	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—TAC1—atopic dermatitis	0.000507	0.00324	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—atopic dermatitis	0.000502	0.0032	CbGpPWpGaD
Treprostinil—Dyspepsia—Dexamethasone—atopic dermatitis	0.000501	0.000723	CcSEcCtD
Treprostinil—Dyspepsia—Betamethasone—atopic dermatitis	0.000501	0.000723	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000498	0.00317	CbGpPWpGaD
Treprostinil—Body temperature increased—Triamcinolone—atopic dermatitis	0.000496	0.000716	CcSEcCtD
Treprostinil—Oedema—Prednisone—atopic dermatitis	0.000496	0.000716	CcSEcCtD
Treprostinil—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000495	0.000714	CcSEcCtD
Treprostinil—Decreased appetite—Betamethasone—atopic dermatitis	0.000495	0.000714	CcSEcCtD
Treprostinil—Decreased appetite—Dexamethasone—atopic dermatitis	0.000495	0.000714	CcSEcCtD
Treprostinil—Infection—Prednisone—atopic dermatitis	0.000493	0.000711	CcSEcCtD
Treprostinil—Fatigue—Betamethasone—atopic dermatitis	0.000491	0.000708	CcSEcCtD
Treprostinil—Fatigue—Dexamethasone—atopic dermatitis	0.000491	0.000708	CcSEcCtD
Treprostinil—Shock—Prednisone—atopic dermatitis	0.000488	0.000704	CcSEcCtD
Treprostinil—Pain—Betamethasone—atopic dermatitis	0.000487	0.000703	CcSEcCtD
Treprostinil—Pain—Dexamethasone—atopic dermatitis	0.000487	0.000703	CcSEcCtD
Treprostinil—Tachycardia—Prednisone—atopic dermatitis	0.000484	0.000698	CcSEcCtD
Treprostinil—Asthenia—Hydrocortisone—atopic dermatitis	0.000478	0.00069	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CCL27—atopic dermatitis	0.000477	0.00304	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR3—atopic dermatitis	0.000476	0.00303	CbGpPWpGaD
Treprostinil—Anorexia—Prednisone—atopic dermatitis	0.000473	0.000682	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—IL5—atopic dermatitis	0.000472	0.00301	CbGpPWpGaD
Treprostinil—Pruritus—Hydrocortisone—atopic dermatitis	0.000472	0.00068	CcSEcCtD
Treprostinil—Feeling abnormal—Betamethasone—atopic dermatitis	0.000469	0.000677	CcSEcCtD
Treprostinil—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000469	0.000677	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—NPS—atopic dermatitis	0.000467	0.00298	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—TAC1—atopic dermatitis	0.000467	0.00298	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000466	0.000672	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000466	0.000672	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CCL17—atopic dermatitis	0.000465	0.00296	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NPS—atopic dermatitis	0.000461	0.00294	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TAC1—atopic dermatitis	0.000461	0.00294	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000458	0.00292	CbGpPWpGaD
Treprostinil—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000456	0.000658	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000452	0.000652	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CXCR3—atopic dermatitis	0.000452	0.00288	CbGpPWpGaD
Treprostinil—Dizziness—Prednisolone—atopic dermatitis	0.000451	0.000651	CcSEcCtD
Treprostinil—Asthenia—Triamcinolone—atopic dermatitis	0.00045	0.00065	CcSEcCtD
Treprostinil—Abdominal pain—Dexamethasone—atopic dermatitis	0.00045	0.00065	CcSEcCtD
Treprostinil—Abdominal pain—Betamethasone—atopic dermatitis	0.00045	0.00065	CcSEcCtD
Treprostinil—Body temperature increased—Dexamethasone—atopic dermatitis	0.00045	0.00065	CcSEcCtD
Treprostinil—Body temperature increased—Betamethasone—atopic dermatitis	0.00045	0.00065	CcSEcCtD
Treprostinil—Asthenia—Methylprednisolone—atopic dermatitis	0.000449	0.000648	CcSEcCtD
Treprostinil—Insomnia—Prednisone—atopic dermatitis	0.000449	0.000647	CcSEcCtD
Treprostinil—Paraesthesia—Prednisone—atopic dermatitis	0.000445	0.000642	CcSEcCtD
Treprostinil—Pruritus—Triamcinolone—atopic dermatitis	0.000444	0.000641	CcSEcCtD
Treprostinil—Pruritus—Methylprednisolone—atopic dermatitis	0.000443	0.000639	CcSEcCtD
Treprostinil—Dizziness—Hydrocortisone—atopic dermatitis	0.000441	0.000636	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000438	0.00279	CbGpPWpGaD
Treprostinil—Dyspepsia—Prednisone—atopic dermatitis	0.000437	0.00063	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000435	0.00278	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL5—atopic dermatitis	0.000434	0.00277	CbGpPWpGaD
Treprostinil—Decreased appetite—Prednisone—atopic dermatitis	0.000431	0.000622	CcSEcCtD
Treprostinil—Rash—Prednisolone—atopic dermatitis	0.00043	0.000621	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—atopic dermatitis	0.00043	0.00062	CcSEcCtD
Treprostinil—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000429	0.000618	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—IL5—atopic dermatitis	0.000428	0.00273	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL17—atopic dermatitis	0.000428	0.00273	CbGpPWpGaD
Treprostinil—Fatigue—Prednisone—atopic dermatitis	0.000428	0.000617	CcSEcCtD
Treprostinil—Headache—Prednisolone—atopic dermatitis	0.000428	0.000617	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—NPS—atopic dermatitis	0.000424	0.0027	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TAC1—atopic dermatitis	0.000424	0.0027	CbGpPWpGaD
Treprostinil—Vomiting—Hydrocortisone—atopic dermatitis	0.000424	0.000611	CcSEcCtD
Treprostinil—Rash—Hydrocortisone—atopic dermatitis	0.00042	0.000606	CcSEcCtD
Treprostinil—Dermatitis—Hydrocortisone—atopic dermatitis	0.00042	0.000606	CcSEcCtD
Treprostinil—Headache—Hydrocortisone—atopic dermatitis	0.000418	0.000602	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000416	0.00265	CbGpPWpGaD
Treprostinil—Dizziness—Triamcinolone—atopic dermatitis	0.000415	0.000599	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—KIF3A—atopic dermatitis	0.000414	0.00264	CbGpPWpGaD
Treprostinil—Dizziness—Methylprednisolone—atopic dermatitis	0.000414	0.000597	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisone—atopic dermatitis	0.000409	0.00059	CcSEcCtD
Treprostinil—Asthenia—Betamethasone—atopic dermatitis	0.000409	0.000589	CcSEcCtD
Treprostinil—Asthenia—Dexamethasone—atopic dermatitis	0.000409	0.000589	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000406	0.000585	CcSEcCtD
Treprostinil—Nausea—Prednisolone—atopic dermatitis	0.000406	0.000585	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000403	0.00257	CbGpPWpGaD
Treprostinil—Pruritus—Dexamethasone—atopic dermatitis	0.000403	0.000581	CcSEcCtD
Treprostinil—Pruritus—Betamethasone—atopic dermatitis	0.000403	0.000581	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000402	0.00257	CbGpPWpGaD
Treprostinil—Vomiting—Triamcinolone—atopic dermatitis	0.000399	0.000576	CcSEcCtD
Treprostinil—Vomiting—Methylprednisolone—atopic dermatitis	0.000398	0.000574	CcSEcCtD
Treprostinil—Nausea—Hydrocortisone—atopic dermatitis	0.000396	0.000571	CcSEcCtD
Treprostinil—Rash—Triamcinolone—atopic dermatitis	0.000396	0.000571	CcSEcCtD
Treprostinil—Dermatitis—Triamcinolone—atopic dermatitis	0.000395	0.00057	CcSEcCtD
Treprostinil—Rash—Methylprednisolone—atopic dermatitis	0.000395	0.00057	CcSEcCtD
Treprostinil—Dermatitis—Methylprednisolone—atopic dermatitis	0.000395	0.000569	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—IL5—atopic dermatitis	0.000394	0.00251	CbGpPWpGaD
Treprostinil—Headache—Triamcinolone—atopic dermatitis	0.000393	0.000567	CcSEcCtD
Treprostinil—Headache—Methylprednisolone—atopic dermatitis	0.000392	0.000566	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—atopic dermatitis	0.000392	0.000566	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—atopic dermatitis	0.000392	0.000566	CcSEcCtD
Treprostinil—Diarrhoea—Dexamethasone—atopic dermatitis	0.00039	0.000562	CcSEcCtD
Treprostinil—Diarrhoea—Betamethasone—atopic dermatitis	0.00039	0.000562	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—KIF3A—atopic dermatitis	0.000381	0.00243	CbGpPWpGaD
Treprostinil—Dizziness—Dexamethasone—atopic dermatitis	0.000377	0.000543	CcSEcCtD
Treprostinil—Dizziness—Betamethasone—atopic dermatitis	0.000377	0.000543	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CCL11—atopic dermatitis	0.000375	0.00239	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CMA1—atopic dermatitis	0.000375	0.00239	CbGpPWpGaD
Treprostinil—Nausea—Triamcinolone—atopic dermatitis	0.000373	0.000538	CcSEcCtD
Treprostinil—Nausea—Methylprednisolone—atopic dermatitis	0.000372	0.000537	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00037	0.00236	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL10—atopic dermatitis	0.000365	0.00233	CbGpPWpGaD
Treprostinil—Vomiting—Betamethasone—atopic dermatitis	0.000362	0.000522	CcSEcCtD
Treprostinil—Vomiting—Dexamethasone—atopic dermatitis	0.000362	0.000522	CcSEcCtD
Treprostinil—Rash—Dexamethasone—atopic dermatitis	0.000359	0.000518	CcSEcCtD
Treprostinil—Rash—Betamethasone—atopic dermatitis	0.000359	0.000518	CcSEcCtD
Treprostinil—Dermatitis—Dexamethasone—atopic dermatitis	0.000359	0.000518	CcSEcCtD
Treprostinil—Dermatitis—Betamethasone—atopic dermatitis	0.000359	0.000518	CcSEcCtD
Treprostinil—Headache—Betamethasone—atopic dermatitis	0.000357	0.000515	CcSEcCtD
Treprostinil—Headache—Dexamethasone—atopic dermatitis	0.000357	0.000515	CcSEcCtD
Treprostinil—Asthenia—Prednisone—atopic dermatitis	0.000356	0.000513	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—STAT6—atopic dermatitis	0.000352	0.00225	CbGpPWpGaD
Treprostinil—Pruritus—Prednisone—atopic dermatitis	0.000351	0.000506	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCL5—atopic dermatitis	0.000346	0.00221	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL11—atopic dermatitis	0.000345	0.0022	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CMA1—atopic dermatitis	0.000345	0.0022	CbGpPWpGaD
Treprostinil—Diarrhoea—Prednisone—atopic dermatitis	0.000339	0.00049	CcSEcCtD
Treprostinil—Nausea—Dexamethasone—atopic dermatitis	0.000338	0.000488	CcSEcCtD
Treprostinil—Nausea—Betamethasone—atopic dermatitis	0.000338	0.000488	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000336	0.00214	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—atopic dermatitis	0.000334	0.00213	CbGpPWpGaD
Treprostinil—Dizziness—Prednisone—atopic dermatitis	0.000328	0.000473	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—STAT6—atopic dermatitis	0.000324	0.00207	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000319	0.00203	CbGpPWpGaD
Treprostinil—Vomiting—Prednisone—atopic dermatitis	0.000315	0.000455	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCL5—atopic dermatitis	0.000314	0.00201	CbGpPWpGaD
Treprostinil—Rash—Prednisone—atopic dermatitis	0.000313	0.000451	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—atopic dermatitis	0.000313	0.000451	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCR5—atopic dermatitis	0.000312	0.00199	CbGpPWpGaD
Treprostinil—Headache—Prednisone—atopic dermatitis	0.000311	0.000448	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000307	0.00196	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR3—atopic dermatitis	0.000305	0.00195	CbGpPWpGaD
Treprostinil—Nausea—Prednisone—atopic dermatitis	0.000295	0.000425	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CCL5—atopic dermatitis	0.000289	0.00185	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000287	0.00183	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—atopic dermatitis	0.000285	0.00182	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR5—atopic dermatitis	0.000283	0.00181	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR3—atopic dermatitis	0.000281	0.00179	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TAC1—atopic dermatitis	0.000272	0.00174	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NPS—atopic dermatitis	0.000272	0.00174	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00027	0.00172	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCR3—atopic dermatitis	0.000267	0.0017	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—atopic dermatitis	0.000262	0.00167	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR5—atopic dermatitis	0.000261	0.00166	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL5—atopic dermatitis	0.000253	0.00161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TAC1—atopic dermatitis	0.000251	0.0016	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NPS—atopic dermatitis	0.000251	0.0016	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARA—atopic dermatitis	0.000249	0.00159	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCR3—atopic dermatitis	0.000246	0.00157	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL5—atopic dermatitis	0.000233	0.00149	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL10—atopic dermatitis	0.000216	0.00138	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL10—atopic dermatitis	0.000199	0.00127	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARA—atopic dermatitis	0.000194	0.00124	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000189	0.0012	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL5—atopic dermatitis	0.000186	0.00118	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—atopic dermatitis	0.00018	0.00115	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000174	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGF—atopic dermatitis	0.000172	0.0011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—atopic dermatitis	0.000171	0.00109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL5—atopic dermatitis	0.000171	0.00109	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—atopic dermatitis	0.000167	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—atopic dermatitis	0.000166	0.00106	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—atopic dermatitis	0.000164	0.00104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGF—atopic dermatitis	0.000158	0.00101	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000158	0.00101	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—atopic dermatitis	0.000154	0.000982	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—atopic dermatitis	0.000151	0.000961	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKBIA—atopic dermatitis	0.000142	0.000905	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKBIA—atopic dermatitis	0.000131	0.000833	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLB1—atopic dermatitis	0.00012	0.000766	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADSL—atopic dermatitis	0.000115	0.000734	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—atopic dermatitis	0.000101	0.000645	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—atopic dermatitis	9.67e-05	0.000617	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—atopic dermatitis	9.62e-05	0.000614	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—atopic dermatitis	9.31e-05	0.000594	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—atopic dermatitis	8.9e-05	0.000568	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—atopic dermatitis	8.9e-05	0.000567	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—atopic dermatitis	8.85e-05	0.000565	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.75e-05	0.000558	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—atopic dermatitis	8.19e-05	0.000522	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—atopic dermatitis	5.68e-05	0.000362	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—atopic dermatitis	5.23e-05	0.000334	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.9e-05	0.000249	CbGpPWpGaD
